tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matt Miksic, 246 are a BUY (79.1%), 46 are a HOLD (14.79%), 19 are a SELL (6.11%).
Analyst Matt Miksic, currently employed at BARCLAYS, carries an average stock price target met ratio of 53.65% that have a potential upside of 18.79% achieved within 324 days.
Matt Miksic’s has documented 640 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LIVN, LivaNova PLC at 21-Aug-2025.
Analyst best performing recommendations are on ISRG (INTUITIVE SURGICAL).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 10/17/2022. The price target of $235 was fulfilled within 8 days with a profit of $44.88 (23.61%) receiving and performance score of 29.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$145
$12.34 (9.30%)
$137
1 months 12 days ago
(18-Jul-2025)
13/14 (92.86%)
$21.33 (17.25%)
365
Hold
$135
$2.34 (1.76%)
$140
1 months 12 days ago
(18-Jul-2025)
5/7 (71.43%)
$11.33 (9.16%)
122
Buy
$145
$12.34 (9.30%)
$139
1 months 12 days ago
(18-Jul-2025)
8/9 (88.89%)
$21.33 (17.25%)
759
Buy
$145
$12.34 (9.30%)
$124
1 months 22 days ago
(08-Jul-2025)
7/8 (87.5%)
$11.64 (8.73%)
316
Buy
$145
$12.34 (9.30%)
$133
4 months 13 days ago
(17-Apr-2025)
2/3 (66.67%)
$14.02 (10.70%)
133
Which stock is Matt Miksic is most bullish on?
Which stock is Matt Miksic is most reserved on?
What Year was the first public recommendation made by Matt Miksic?
